InfiCure Bio is present at NLSDays 2017 in Malmö on September 13th-14th. Take the chance to come and talk to us about our amazing N-IF model and other models currently in our pipeline. NLSDays is an excellent place to discuss new and emerging life science questions and as you know, we have fibrosis in focus.
About wpadminThis author has not yet filled in any details.
So far wpadmin has created 21 blog entries.
InfiCure Bio was one of eight Nordic companies presenting at the 29th Seed Forum in New York on Wednesday June 7th. Last Minute Brief was held at Nordic Innovation House, WeWork Grand Central, on Tuesday June 6ht and a group picture was taken at Lexington Ave. The 29th Seed Forum had a great interest from numerous [...]
InfiCure Bio is one of 9 Nordic companies which will meet with American investors in New York on 7th of June. The three Swedish companies are InfiCure Bio, Smartster and Poseidon. Yesterday, the Swedish companies met at Carnegie Investment Bank to present their investor pitches and get feed-back from Björn Jansson, CEO of Carnegie, and Viktor Lindberg, Analyst [...]
InfiCure Bio is awarded Connect Company of 2016 in northern Sweden. There were 26 companies in the competition and the winner was announced at the annual meeting of Connect Norr. The company will besides the honor of being the winner be present at the largest investment meeting in Sweden - Connect2Capital 2018 in Gothenburg.
InfiCure Bio was selected as 2016 Connect Company in Västerbotten at the annual meeting of Connect in Umeå. Five companies were nominated for the prize and the winner was chosen by the Board of Connect Sweden. InfiCure Bio is now nominated to compete for the title 2016 Connect Company in northern Sweden. Read more about the event [...]
We are happy to announce that Vinnova has decided to fund our application for Innovative Start-up. This funding opens up for additional validation experiments on the N-IF mouse model and a step forward for InfiCure Bio.
InfiCure Bio will be at Swiss Nordic Bio Connecting Healthcare Innovations, Investors and Industry in Zurich on February 8th. Come meet us! […]
The unique fibrosis model offered by InfiCure is attracting international attention. Last month the startup signed their first contract for a full-service preclinical pilot study to test two substances for an american client in Boston. The trial i currently underway, with all lab work beeing done on location in Umeå. […]
InfiCure Bio, a life-science company in the field of inflammation and fibrosis, has characterized a new preclinical model that spontaneously develops chronic inflammation and fibrosis in multiple organs. The model is called the non-obese diabetic inflammation and fibrosis (N-IF) mouse and you can read all about it here. […]
Life science-företaget Inficure Bio har som vision att bli världsledande inom tester av anti-fibrotiska läkemedel. Företaget har tagit fram en modell som spontant utvecklar fibros i bland annat lever, njure och lunga. […]